Literature DB >> 1177640

The treatment of glottic carcinoma: an analysis of 800 cases.

N V Hawkins.   

Abstract

All patients with cancer of the glottis seen at the Ontario Cancer Institute from 1955 to 1971 are reviewed. Changes in referral patterns and treatment policy are noted. Particular attention is given to those patients who received radiation for cure, and the place of laryngectomy in their subsequent management is examined. Of the estimated incidence of the disease in the geographic region served, 95 percent are now being seen and of these 97 percent receive treatment with curative intent. Two-thirds or 67 percent are cured at five years and their larynges intact, while a further 18 percent are cured by subsequent laryngectomy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1177640     DOI: 10.1288/00005537-197509000-00009

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  6 in total

1.  mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma.

Authors:  Lijing Zhao; Bo Teng; Lianji Wen; Qingjie Feng; Hebin Wang; Na Li; Yafang Wang; Zuowen Liang
Journal:  Int J Clin Exp Med       Date:  2014-02-15

Review 2.  Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer.

Authors:  Jeffrey M Vainshtein; Vivian F Wu; Matthew E Spector; Carol R Bradford; Gregory T Wolf; Francis P Worden
Journal:  Expert Rev Anticancer Ther       Date:  2013-09       Impact factor: 4.512

3.  Surgeon information giving practices prior to laryngectomy: a national survey.

Authors:  N D Stafford; R J Lewin; P Nash; G F Hardman
Journal:  Ann R Coll Surg Engl       Date:  2001-11       Impact factor: 1.891

4.  A phase I clinical trial of prolonged infusion of hydroxyurea in combination with hyperfractionated, accelerated, external radiation therapy in patients with advanced squamous cell cancer of the head and neck.

Authors:  J J Beitler; R V Smith; H Haynes; C E Silver; A Quish; T Kotz; M Serrano; A Brook; S Wadler
Journal:  Invest New Drugs       Date:  1998       Impact factor: 3.850

Review 5.  The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality.

Authors:  Daris Ferrari; Maria Grazia Ghi; Ciro Franzese; Carla Codecà; Max Gau; Jerome Fayette
Journal:  Front Oncol       Date:  2020-01-23       Impact factor: 6.244

6.  In vitro and in vivo effect of 5-FC combined gene therapy with TNF-α and CD suicide gene on human laryngeal carcinoma cell line Hep-2.

Authors:  Li-Ping Chai; Zhang-Feng Wang; Wei-Ying Liang; Lei Chen; Dan Chen; An-Xun Wang; Zhao-Qiang Zhang
Journal:  PLoS One       Date:  2013-04-11       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.